ASCELIA PHARMA

ASCELIA PHARMA is a biotech company providing novel drugs that address rare cancer conditions. It offers mangoral, a novel non-gadolinium contrast agent, which is in phase 3 for use in MRI scans of the liver; and oncoral, a novel oral chemotherapy tablet, which is in Phase 2 for the treatment of gastric cancer.